Guardant Health director granted 2,711 RSUs

Azar Alex M II reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Azar Alex M II reported acquisition or exercise transactions in this Form 4 filing.

Guardant Health director Azar Alex M II received a grant of 2,711 Restricted Stock Units (RSUs) tied to the company’s common stock. Each RSU represents the right to receive one share of common stock for no cash payment. The award vests in full on June 17, 2026, the one-year anniversary of the grant date, or on the date of Guardant Health’s next annual meeting of stockholders, whichever occurs earlier. Following this Form 4 transaction, Azar holds 2,711 RSUs directly.

Insider Trade Summary

Grant/Award: 2,711 shares

Grant/Award 1 txn

Insider Azar Alex M II

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units	2,711	$0.00	$0.00

Holdings After Transaction: Restricted Stock Units — 2,711 contracts (Direct)

Footnotes (2)

1. F1. The restricted stock unit award vests in full on the one-year anniversary of the grant date, June 17, 2026, or the date of the Company's next annual meeting of stockholders, whichever is earlier.
2. F2. Not applicable for Restricted Stock Units.

Key Figures

RSUs granted: 2,711 units RSU grant price: $0.0000 per unit Underlying common shares: 2,711 shares +2 more

5 metrics

RSUs granted 2,711 units Restricted Stock Units awarded on June 17, 2026 grant date reference

RSU grant price $0.0000 per unit Reported transaction price per Restricted Stock Unit

Underlying common shares 2,711 shares Common stock underlying the RSU grant

Holdings after transaction 2,711 RSUs Total derivative holdings following the grant

Vesting date June 17, 2026 One-year anniversary of the grant date, or earlier annual meeting

Key Terms

Restricted Stock Units, Common Stock, grant/award acquisition

3 terms

Restricted Stock Units financial

"The restricted stock unit award vests in full on the one-year anniversary"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Common Stock financial

"underlying_security_title": "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

grant/award acquisition financial

"transaction_action": "grant/award acquisition""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Guardant Health (GH) report for Azar Alex M II?

Guardant Health reported that director Azar Alex M II received 2,711 Restricted Stock Units. These RSUs are a stock-based compensation award that will convert into an equal number of common shares once they vest under the disclosed schedule.

How many Restricted Stock Units did the Guardant Health director receive?

The director received 2,711 Restricted Stock Units. Each unit represents a right to receive one share of Guardant Health common stock, providing equity-based compensation that aligns the director’s interests with shareholders once the award vests.

When do the 2,711 RSUs granted by Guardant Health vest?

The 2,711 RSUs vest in full on June 17, 2026, the one-year anniversary of the grant date, or on the date of Guardant Health’s next annual stockholders’ meeting, whichever happens earlier under the terms of the award.

Did Azar Alex M II buy or sell Guardant Health shares in this Form 4?

The Form 4 shows an acquisition through a grant of 2,711 Restricted Stock Units, not an open-market purchase or sale. It reflects compensation awarded by Guardant Health rather than a discretionary trade in the company’s stock.

What is the exercise or purchase price for the Guardant Health RSU award?

The reported transaction lists a price of $0.0000 per unit, reflecting that Restricted Stock Units do not require a purchase price. Instead, once vested, each RSU converts into one share of Guardant Health common stock without additional cash payment.

How many Guardant Health RSUs does Azar Alex M II hold after this grant?

After this transaction, Azar Alex M II holds 2,711 Restricted Stock Units. This entire position comes from the newly reported grant, as total derivative holdings following the transaction equal the number of units awarded.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/22/2026 - 05:50 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Azar Alex M II

(Last) (First) (Middle)

3100 HANOVER STREET

(Street)

PALO ALTO CALIFORNIA 94304

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Guardant Health, Inc. [ GH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/17/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	$0	06/17/2026		A		2,711		(1)	(2)	Common Stock	2,711	$0	2,711	D

Explanation of Responses:

1. The restricted stock unit award vests in full on the one-year anniversary of the grant date, June 17, 2026, or the date of the Company's next annual meeting of stockholders, whichever is earlier.

2. Not applicable for Restricted Stock Units.

Remarks:

	/s/ John G. Saia, as attorney-in-fact for Alex M. Azar II	06/22/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)